SCHEMBL27361970

SCHEMBL27361970

N#CC1(c2cccc(Br)c2)CC(F)(F)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.35
MGAT2 Q10469 1/20 0.33
WDR5 P61964 4/20 0.33
CHRNA1 P02708 1/20 0.32
CHRNG P07510 1/20 0.32
CHRNB1 P11230 1/20 0.32
CHRNB2 P17787 1/20 0.32
SLC6A2 P23975 1/20 0.32
CHRNB4 P30926 1/20 0.32
SLC6A4 P31645 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
SLC6A3 Q01959 1/20 0.32
CHRND Q07001 1/20 0.32
HCAR3 P49019 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
BACE1 P56817 1/20 0.32
ALDH1A1 P00352 2/20 0.31
OPRM1 P35372 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29841501 1.00 KMT2A (0.35) KMT2AMGAT2WDR5CHRNA1CHRNG
SCHEMBL27361622 0.83 KMT2A (0.38) KMT2AMGAT2WDR5CHRNA1CHRNG
SCHEMBL30520809 0.83 KMT2A (0.38) KMT2AWDR5CHRNA1CHRNGCHRNB1
SCHEMBL31507302 0.83 KMT2A (0.38) KMT2AMGAT2WDR5CHRNA1CHRNG
SCHEMBL3206919 0.82 KMT2A (0.45) KMT2AWDR5OPRM1
SCHEMBL29237427 0.81 CHRNA1 (0.42) KMT2AMGAT2WDR5CHRNA1CHRNG
SCHEMBL30217022 0.81 CHRNA1 (0.42) KMT2AMGAT2WDR5CHRNA1CHRNG
SCHEMBL22832485 0.80 KMT2A (0.42) KMT2AMGAT2WDR5CHRNA1CHRNG
SCHEMBL1492681 0.79 WDR5 (0.46) KMT2AWDR5BACE1ALDH1A1OPRM1
SCHEMBL17632371 0.79 WDR5 (0.46) KMT2AWDR5ALDH1A1OPRM1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4573085-A1 SUBSTITUTED PYRIDINONE COMPOUNDS AS CBL-B INHIBITORS Glenmark Pharmaceuticals Limited (IN) 2025-06-25 EP disclosed
WO-2024255762-A1 CBL-B INHIBITOR 上海齐鲁制药研究中心有限公司 2024-12-19 WO disclosed
WO-2024245264-A1 CBL-B INHIBITOR AND USE THEREOF 海南先声再明医药股份有限公司 2024-12-05 WO disclosed
CN-114728938-B Tetrahydroisoquinoline spiro compounds as PRMT5 inhibitors 南京再明医药有限公司 2024-05-24 CN disclosed
WO-2024077236-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS HOTSPOT THERAPEUTICS, INC. (US) 2024-04-11 WO disclosed
WO-2024062363-A1 BICYCLIC HETEROCYCLIC COMPOUNDS AS CBL-B INHIBITORS GLENMARK PHARMACEUTICALS LTD (IN) 2024-03-28 WO disclosed
WO-2024038378-A1 SUBSTITUTED PYRIDINONE COMPOUNDS AS CBL-B INHIBITORS GLENMARK PHARMACEUTICALS LTD (IN) 2024-02-22 WO disclosed
WO-2024038378-A1 SUBSTITUTED PYRIDINONE COMPOUNDS AS CBL-B INHIBITORS GLENMARK PHARMACEUTICALS LTD (IN) 2024-02-22 WO disclosed
CN-114728938-A Tetrahydroisoquinoline spiro compounds as PRMT5 inhibitors 江苏先声药业有限公司 2022-07-08 CN disclosed